• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性出血性毛细血管扩张症中中性粒细胞胞外陷阱释放受损与贫血相关的T细胞缺陷

Impaired Release of Neutrophil Extracellular Traps and Anemia-Associated T Cell Deficiency in Hereditary Hemorrhagic Telangiectasia.

作者信息

Droege Freya, Pylaeva Ekaterina, Siakaeva Elena, Bordbari Sharareh, Spyra Ilona, Thangavelu Kruthika, Lueb Carolin, Domnich Maksim, Lang Stephan, Geisthoff Urban, Jablonska Jadwiga

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, Essen University Hospital, University Duisburg-Essen, Hufelandstrasse 55, 45147 Essen, Germany.

Translational Oncology, Department of Otorhinolaryngology, University Hospital Essen, University Duisburg-Essen, Hufelandstrasse 55, 45147 Essen, Germany.

出版信息

J Clin Med. 2020 Mar 12;9(3):767. doi: 10.3390/jcm9030767.

DOI:10.3390/jcm9030767
PMID:32178330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7141391/
Abstract

Hereditary hemorrhagic telangiectasia (HHT) is characterized by mucocutaneous telangiectases and visceral vascular malformations. Individuals suffering from HHT have a significantly increased risk of bacterial infections, but the mechanisms involved in this are not clear. White blood cell subpopulations were estimated with flow cytometry in 79 patients with HHT and 45 healthy individuals, and association with clinicopathological status was assessed. A prominent decrease in absolute numbers of T cells in HHT was revealed (0.7 (0.5-1.1) vs. 1.3 (0.8-1.6), 10/mL, < 0.05), and in multivariate regression analysis, hemoglobin level was associated with lymphopenia (OR = 0.625, 95% CI: 0.417-0.937, < 0.05). Although no changes in absolute numbers of neutrophils and monocytes were observed, we revealed a significant impairment of neutrophil antibacterial functions in HHT ( = 9), compared to healthy individuals ( = 7), in vitro. The release of neutrophil extracellular traps (NETs) against MOI10 was significantly suppressed in HHT (mean area per cell, mm: 76 (70-92) vs. 121 (97-128), < 0.05), due to impaired filamentous actin organization (% of positive cells: 69 (59-77) vs. 92 (88-94), < 0.05). To conclude, this study reveals the categories of patients with HHT that are prone to immunosuppression and require careful monitoring, and suggests a potential therapeutic strategy based on the functional activation of neutrophils.

摘要

遗传性出血性毛细血管扩张症(HHT)的特征为黏膜皮肤毛细血管扩张和内脏血管畸形。HHT患者发生细菌感染的风险显著增加,但其相关机制尚不清楚。我们采用流式细胞术对79例HHT患者和45名健康个体的白细胞亚群进行了评估,并分析了其与临床病理状态的相关性。结果显示,HHT患者的T细胞绝对数量显著减少(0.7(0.5 - 1.1)对1.3(0.8 - 1.6),×10⁹/mL,P < 0.05),多因素回归分析表明,血红蛋白水平与淋巴细胞减少相关(OR = 0.625,95%CI:0.417 - 0.937,P < 0.05)。虽然未观察到中性粒细胞和单核细胞绝对数量的变化,但与健康个体(n = 7)相比,我们发现HHT患者(n = 9)的中性粒细胞抗菌功能存在显著损害。在体外,HHT患者针对MOI 10的中性粒细胞胞外陷阱(NETs)释放显著受到抑制(每个细胞的平均面积,mm²:76(70 - 92)对121(97 - 128),P < 0.05),这是由于丝状肌动蛋白组织受损(阳性细胞百分比:69(59 - 77)对92(88 - 94),P < 0.05)。总之,本研究揭示了HHT患者中易于发生免疫抑制且需要密切监测的类别,并提出了基于中性粒细胞功能激活的潜在治疗策略。

相似文献

1
Impaired Release of Neutrophil Extracellular Traps and Anemia-Associated T Cell Deficiency in Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症中中性粒细胞胞外陷阱释放受损与贫血相关的T细胞缺陷
J Clin Med. 2020 Mar 12;9(3):767. doi: 10.3390/jcm9030767.
2
Immunological abnormalities associated with hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症相关的免疫异常。
J Intern Med. 2013 Oct;274(4):351-62. doi: 10.1111/joim.12098. Epub 2013 Jul 4.
3
[Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].[贝伐单抗:遗传性出血性毛细血管扩张症治疗的新突破]
Rev Med Interne. 2015 Sep;36(9):623-5. doi: 10.1016/j.revmed.2014.11.004. Epub 2015 Jan 13.
4
Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者毛细血管扩张组织的全基因组表达谱分析
Microvasc Res. 2015 May;99:118-26. doi: 10.1016/j.mvr.2015.04.002. Epub 2015 Apr 16.
5
Cerebral vascular malformations in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中的脑血管畸形。
J Neurosurg. 2014 Jan;120(1):87-92. doi: 10.3171/2013.10.JNS122402. Epub 2013 Nov 15.
6
Altered expressions of CXCR4 and CD26 on T-helper lymphocytes in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症 T 辅助淋巴细胞中 CXCR4 和 CD26 的表达改变。
Orphanet J Rare Dis. 2021 Dec 14;16(1):511. doi: 10.1186/s13023-021-02139-y.
7
Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.影响内皮糖蛋白近端启动子的突变作为1型遗传性出血性毛细血管扩张症的起源。
BMC Med Genet. 2017 Feb 23;18(1):20. doi: 10.1186/s12881-017-0380-0.
8
Trauma Can Induce Telangiectases in Hereditary Hemorrhagic Telangiectasia.创伤可诱发遗传性出血性毛细血管扩张症中的毛细血管扩张。
J Clin Med. 2020 May 17;9(5):1507. doi: 10.3390/jcm9051507.
9
Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.遗传性出血性毛细血管扩张症患者脑动静脉畸形的患病率和特征:系统评价和荟萃分析。
J Neurosurg. 2017 Aug;127(2):302-310. doi: 10.3171/2016.7.JNS16847. Epub 2016 Oct 21.
10
Central nervous system manganese induced lesions and clinical consequences in patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者中枢神经系统锰诱导的病变及临床后果
Orphanet J Rare Dis. 2017 May 18;12(1):92. doi: 10.1186/s13023-017-0632-2.

引用本文的文献

1
The Role of Thalidomide and Its Analogs in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Systematic Review.沙利度胺及其类似物在遗传性出血性毛细血管扩张症治疗中的作用:一项系统评价
J Clin Med. 2024 Sep 12;13(18):5404. doi: 10.3390/jcm13185404.
2
Increased Risk for Infections and Allergic Disease in Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症患者感染和过敏性疾病风险增加。
J Clin Med. 2024 Jun 27;13(13):3752. doi: 10.3390/jcm13133752.
3
Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT).

本文引用的文献

1
Clonal and Quantitative In Vivo Assessment of Hematopoietic Stem Cell Differentiation Reveals Strong Erythroid Potential of Multipotent Cells.体内克隆和定量评估造血干细胞分化,揭示多能细胞的强烈红细胞生成潜力。
Stem Cell Reports. 2019 Apr 9;12(4):801-815. doi: 10.1016/j.stemcr.2019.02.007. Epub 2019 Mar 21.
2
Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations.遗传性出血性毛细血管扩张症中的感染与疫苗接种:基于微生物学证据的考量
Haematologica. 2018 Oct;103(10):e492-e495. doi: 10.3324/haematol.2018.203968.
3
Aging of the immune system causes reductions in muscle stem cell populations, promotes their shift to a fibrogenic phenotype, and modulates sarcopenia.
使用多种体外系统分析疾病(遗传性出血性毛细血管扩张症,即HHT)的多个方面。
Cell Biosci. 2024 May 22;14(1):65. doi: 10.1186/s13578-024-01247-z.
4
Tacrolimus as a Promising Drug for Epistaxis and Gastrointestinal Bleeding in HHT.他克莫司作为治疗遗传性出血性毛细血管扩张症鼻出血和胃肠道出血的一种有前景的药物。
J Clin Med. 2023 Nov 29;12(23):7410. doi: 10.3390/jcm12237410.
5
Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Improves Leukocyte Energy Metabolism in Hereditary Hemorrhagic Telangiectasia.缺氧诱导因子脯氨酰羟化酶抑制剂改善遗传性出血性毛细血管扩张症患者的白细胞能量代谢
Life (Basel). 2023 Aug 9;13(8):1708. doi: 10.3390/life13081708.
6
Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中缺氧诱导因子调节的改变。
Sci Rep. 2022 Apr 7;12(1):5877. doi: 10.1038/s41598-022-09759-9.
7
Altered expressions of CXCR4 and CD26 on T-helper lymphocytes in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症 T 辅助淋巴细胞中 CXCR4 和 CD26 的表达改变。
Orphanet J Rare Dis. 2021 Dec 14;16(1):511. doi: 10.1186/s13023-021-02139-y.
8
Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review.基于内皮糖蛋白/CD105 的癌症和心血管疾病影像学研究:系统评价。
Int J Mol Sci. 2021 Apr 30;22(9):4804. doi: 10.3390/ijms22094804.
免疫系统的衰老导致肌肉干细胞群体减少,促使它们向成纤维表型转化,并调节肌肉减少症。
FASEB J. 2019 Jan;33(1):1415-1427. doi: 10.1096/fj.201800973R. Epub 2018 Aug 21.
4
ROS and glutathionylation balance cytoskeletal dynamics in neutrophil extracellular trap formation.活性氧和谷胱甘肽化作用在中性粒细胞胞外诱捕网形成过程中平衡细胞骨架动力学。
J Cell Biol. 2017 Dec 4;216(12):4073-4090. doi: 10.1083/jcb.201611168. Epub 2017 Nov 17.
5
British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations.英国胸科学会肺动静脉畸形临床声明。
Thorax. 2017 Dec;72(12):1154-1163. doi: 10.1136/thoraxjnl-2017-210764.
6
Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.内皮糖蛋白和 alk1 作为遗传性出血性毛细血管扩张症的治疗靶点。
Expert Opin Ther Targets. 2017 Oct;21(10):933-947. doi: 10.1080/14728222.2017.1365839. Epub 2017 Aug 20.
7
T cell exhaustion: from pathophysiological basics to tumor immunotherapy.T细胞耗竭:从病理生理基础到肿瘤免疫治疗
Cell Commun Signal. 2017 Jan 5;15(1):1. doi: 10.1186/s12964-016-0160-z.
8
Impact of iron deficiency anemia on the function of the immune system in children.缺铁性贫血对儿童免疫系统功能的影响。
Medicine (Baltimore). 2016 Nov;95(47):e5395. doi: 10.1097/MD.0000000000005395.
9
The Role of Immunosenescence in the Development of Age-Related Diseases.免疫衰老在年龄相关性疾病发生发展中的作用。
Rev Invest Clin. 2016 Mar-Apr;68(2):84-91.
10
Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response.巨噬细胞中缺乏内皮糖蛋白的小鼠表现出免疫反应受损。
PLoS Genet. 2016 Mar 24;12(3):e1005935. doi: 10.1371/journal.pgen.1005935. eCollection 2016 Mar.